Trial Profile
Prospective, single-centre study investigating the safety and efficacy of Cyclophosphamide, Gemcitabine, Vinorelbine and Prednisone regimen (CGEV) in patients with hodgkin's lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2016
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Gemcitabine (Primary) ; Prednisone (Primary) ; Vinorelbine (Primary)
- Indications Hodgkin's disease
- Focus Adverse reactions; Therapeutic Use
- 21 Jan 2016 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology